Negative regulation by 'KIT:sSCF dimer:KIT:type I KIT binding TKIs: [plasma membrane]' Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Cite Us!